Taken together, these findings propose that the combined anti-Ang-2/anti-VEGF therapy may ameliorate Ang-2 and VEGF-mediated microenvironmental changes in hypoxic perivascular niches that are essential for successful metastatic tumor outgrowth in the brain. This evidence concerns the gene ANGPT2 and neoplasm.